FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169232238> ?p ?o ?g. }

• W3169232238 endingPage "132" @default.
• W3169232238 startingPage "123" @default.
• W3169232238 abstract "<b><i>Background:</i></b> Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney disease (CKD) on dialysis. Mortality rates are still unacceptably high even though they have fallen in the past 2 decades. Hyperphosphatemia (elevated serum phosphate levels) is seen in almost all patients with advanced CKD and is by far the largest remaining modifiable contributor to CKD mortality. <b><i>Summary:</i></b> Phosphate retention drives multiple physiological mechanisms linked to increased risk of CVD. Fibroblast growth factor 23 and parathyroid hormone (PTH) levels, both of which have been suggested to have direct pathogenic CV effects, increase in response to phosphate retention. Phosphate, calcium, and PTH levels are linked in a progressively worsening cycle. Maladaptive upregulation of phosphate absorption is also likely to occur further exacerbating hyperphosphatemia. Even higher phosphate levels within the normal range may be a risk factor for vascular calcification and, thus, CV morbidity and mortality. A greater degree of phosphate control is important to reduce the risk of CV morbidity and mortality. Improved phosphate control and regular monitoring of phosphate levels are guideline-recommended, established clinical practices. There are several challenges with the current phosphate management approaches in patients with CKD on dialysis. Dietary restriction of phosphate and thrice-weekly dialysis alone are insufficient/unreliable to reduce phosphate to &#x3c;5.5 mg/dL. Even with the addition of phosphate binders, the only pharmacological treatment currently indicated for hyperphosphatemia, the majority of patients are unable to achieve and maintain phosphate levels &#x3c;5.5 mg/dL (or more normal levels) [PhosLo® gelcaps (calcium acetate): 667 mg (prescribing information), 2011, VELPHORO®: (Sucroferric oxyhydroxide) (prescribing information), 2013, FOSRENAL®: (Lanthanum carbonate) (prescribing information), 2016, AURYXIA®: (Ferric citrate) tablets (prescribing information), 2017, RENVELA®: (Sevelamer carbonate) (prescribing information), 2020, RealWorld dynamix. Dialysis US: Spherix Global Insights, 2019]. Phosphate binders do not target the primary pathway of phosphate absorption (paracellular), have limited binding capacity, and bind nonspecifically [PhosLo® gelcaps (calcium acetate): 667 mg (prescribing information). 2013, VELPHORO®: (Sucroferric oxyhydroxide) (prescribing information), 2013, FOSRENAL®: (Lanthanum carbonate) (prescribing information), 2016, AURYXIA®: (Ferric citrate) tablets (prescribing information), 2017, RENVELA®: (Sevelamer carbonate) (prescribing information) 2020]. <b><i>Key Messages:</i></b> Despite current phosphate management strategies, most patients on dialysis are unable to consistently achieve target phosphate levels, indicating a need for therapeutic innovations [RealWorld dynamix. Dialysis US: Spherix Global Insights, 2019]. Given a growing evidence base that the dominant mechanism of phosphate absorption is the intestinal paracellular pathway, new therapies are investigating ways to reduce phosphate levels by blocking absorption through the paracellular pathway." @default.
• W3169232238 created "2021-06-22" @default.
• W3169232238 creator A5008382551 @default.
• W3169232238 date "2021-01-01" @default.
• W3169232238 modified "2023-10-16" @default.
• W3169232238 title "Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality" @default.
• W3169232238 cites W1548377625 @default.
• W3169232238 cites W1686128879 @default.
• W3169232238 cites W1833121085 @default.
• W3169232238 cites W1860671097 @default.
• W3169232238 cites W1967604492 @default.
• W3169232238 cites W1968486375 @default.
• W3169232238 cites W1970925770 @default.
• W3169232238 cites W1976344984 @default.
• W3169232238 cites W1978456616 @default.
• W3169232238 cites W1982986170 @default.
• W3169232238 cites W1983133134 @default.
• W3169232238 cites W1983946999 @default.
• W3169232238 cites W1984380841 @default.
• W3169232238 cites W1988943870 @default.
• W3169232238 cites W1991218855 @default.
• W3169232238 cites W1993099421 @default.
• W3169232238 cites W2000458563 @default.
• W3169232238 cites W2002298764 @default.
• W3169232238 cites W2004494117 @default.
• W3169232238 cites W2007894159 @default.
• W3169232238 cites W2011676132 @default.
• W3169232238 cites W2021852822 @default.
• W3169232238 cites W2024288736 @default.
• W3169232238 cites W2027479037 @default.
• W3169232238 cites W2030174339 @default.
• W3169232238 cites W2035221187 @default.
• W3169232238 cites W2043985844 @default.
• W3169232238 cites W2049581527 @default.
• W3169232238 cites W2050059058 @default.
• W3169232238 cites W2056263872 @default.
• W3169232238 cites W2057817751 @default.
• W3169232238 cites W2059099969 @default.
• W3169232238 cites W2063773186 @default.
• W3169232238 cites W2072064912 @default.
• W3169232238 cites W2072333386 @default.
• W3169232238 cites W2072718197 @default.
• W3169232238 cites W2074430782 @default.
• W3169232238 cites W2077053969 @default.
• W3169232238 cites W2077142615 @default.
• W3169232238 cites W2077542041 @default.
• W3169232238 cites W2086883857 @default.
• W3169232238 cites W2087189144 @default.
• W3169232238 cites W2087773817 @default.
• W3169232238 cites W2092959403 @default.
• W3169232238 cites W2097969657 @default.
• W3169232238 cites W2100168006 @default.
• W3169232238 cites W2105719970 @default.
• W3169232238 cites W2106504544 @default.
• W3169232238 cites W2106564101 @default.
• W3169232238 cites W2107207648 @default.
• W3169232238 cites W2108306240 @default.
• W3169232238 cites W2113128072 @default.
• W3169232238 cites W2122037712 @default.
• W3169232238 cites W2129282190 @default.
• W3169232238 cites W2131064361 @default.
• W3169232238 cites W2132348458 @default.
• W3169232238 cites W2138484848 @default.
• W3169232238 cites W2138829372 @default.
• W3169232238 cites W2140575711 @default.
• W3169232238 cites W2149424722 @default.
• W3169232238 cites W2150872128 @default.
• W3169232238 cites W2155099737 @default.
• W3169232238 cites W2159532786 @default.
• W3169232238 cites W2160279137 @default.
• W3169232238 cites W2164721814 @default.
• W3169232238 cites W2164919062 @default.
• W3169232238 cites W2165941640 @default.
• W3169232238 cites W2302526174 @default.
• W3169232238 cites W2302628159 @default.
• W3169232238 cites W2328615536 @default.
• W3169232238 cites W2408915079 @default.
• W3169232238 cites W2464370607 @default.
• W3169232238 cites W2531037478 @default.
• W3169232238 cites W2535312680 @default.
• W3169232238 cites W2593849730 @default.
• W3169232238 cites W2594115608 @default.
• W3169232238 cites W2743203236 @default.
• W3169232238 cites W2772674286 @default.
• W3169232238 cites W2784781807 @default.
• W3169232238 cites W2789391161 @default.
• W3169232238 cites W2791427360 @default.
• W3169232238 cites W2802094512 @default.
• W3169232238 cites W2890296042 @default.
• W3169232238 cites W2891791059 @default.
• W3169232238 cites W2895682445 @default.
• W3169232238 cites W2899841216 @default.
• W3169232238 cites W2902048630 @default.
• W3169232238 cites W2911491919 @default.
• W3169232238 cites W2913915144 @default.
• W3169232238 cites W2922107684 @default.
• W3169232238 cites W2930089657 @default.
• W3169232238 cites W2951533026 @default.

• next